Warneford to UNIPART in Cowley. A date for the move has yet to be confirmed. This will provide an opportunity to work with the University of Oxford and OUH Joint research Office who are also relocating. The six monthly R&D Report to the Board was submitted in March 2017. 7.11 Areas of unsatisfactory compliance/areas of risk across R&D in the Trust were as follows CRIS - There has been one incident of unsatisfactory compliance which was located by way of the CRIS audit. A researcher was searching on a field which was not in their original application. This was brought to the attention of the CRIS Oversight Group and the researcher concerned and the reason behind why this additional field was being used was established and the researcher was reminded that all CRIS searches should remain within their original terms or an amendment to their application should be submitted to the CRIS Oversight Group for approval before conducting the search. CRIS - Files which are saved onto Trust drives (by the CRIS coordinator) for the CRIS researchers to access via the Trust network are controlled by policy not via a physical control. It is the responsibility of the researcher, in line with the terms and conditions of their CRIS application to ensure the files remain within the Trust firewalls and are not emailed or saved to an external drive. This is reliant on policy alone. CRN are struggling to recruit research nurses to the team, with two vacancies. Pharmacy - Ad hoc temperature monitoring of transit temperature between CPSU and Warneford sites have shown deviations outside of approved range (temp fallen to 14°C on several occasions). This is just with SCAS transport. Not an issue with taxi transport. No IMP affected, however this may limit our ability to use SCAS runs for clinical trial medicines. Pharmacy - Overcrowding: Storage space at the dispensary (CPSU) is very tight and there may be issues with storage capacity if this is not resolved. There is currently no space to take on any new controlled drug studies Pharmacy - New CTIMP opened at Abingdon OOH. Minimal pharmacy oversight of IMP. Temp monitoring in storage area shows some deviations
Warneford to UNIPART in Cowley. A date for the move has yet to be confirmed. This will provide an opportunity to work with the University of Oxford and OUH Joint research Office who are also relocating. The six monthly R&D Report to the Board was submitted in March 2017. 7.11 Areas of unsatisfactory compliance/areas of risk across R&D in the Trust were as follows CRIS - There has been one incident of unsatisfactory compliance which was located by way of the CRIS audit. A researcher was searching on a field which was not in their original application. This was brought to the attention of the CRIS Oversight Group and the researcher concerned and the reason behind why this additional field was being used was established and the researcher was reminded that all CRIS searches should remain within their original terms or an amendment to their application should be submitted to the CRIS Oversight Group for approval before conducting the search. CRIS - Files which are saved onto Trust drives (by the CRIS coordinator) for the CRIS researchers to access via the Trust network are controlled by policy not via a physical control. It is the responsibility of the researcher, in line with the terms and conditions of their CRIS application to ensure the files remain within the Trust firewalls and are not emailed or saved to an external drive. This is reliant on policy alone. CRN are struggling to recruit research nurses to the team, with two vacancies. Pharmacy - Ad hoc temperature monitoring of transit temperature between CPSU and Warneford sites have shown deviations outside of approved range (temp fallen to 14°C on several occasions). This is just with SCAS transport. Not an issue with taxi transport. No IMP affected, however this may limit our ability to use SCAS runs for clinical trial medicines. Pharmacy - Overcrowding: Storage space at the dispensary (CPSU) is very tight and there may be issues with storage capacity if this is not resolved. There is currently no space to take on any new controlled drug studies Pharmacy - New CTIMP opened at Abingdon OOH. Minimal pharmacy oversight of IMP. Temp monitoring in storage area shows some deviations
94_BOD_Oxford-Health-2017-BoD-Report-Coversheet-v.2-FINAL-July-2017.docx